Alnylam Pharmaceuticals
ALNY
#728
Rank
HK$268.62 B
Marketcap
HK$2,008
Share price
2.55%
Change (1 day)
-42.19%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company